Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
    • CFP AI policy
    • Politique du MFC en matière d'IA
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://cfpc.my.site.com/s/login/
    • Careers and Locums

User menu

  • My alerts

Search

  • Advanced search
The College of Family Physicians of Canada
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://cfpc.my.site.com/s/login/
    • Careers and Locums
  • My alerts
The College of Family Physicians of Canada

Advanced Search

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
    • CFP AI policy
    • Politique du MFC en matière d'IA
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • RSS feeds
  • Follow cfp Template on Twitter
  • LinkedIn
  • Instagram
OtherPractice

Electronic cigarettes: help, hurt, or hype?

Elfriede Cross, Scott Garrison and Michael R. Kolber
Canadian Family Physician January 2016; 62 (1) 51;
Elfriede Cross
Emergency medicine resident, at the University of Alberta in Edmonton.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott Garrison
Associate Professor in the Department of Family Medicine, at the University of Alberta in Edmonton.
MD CCFP PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael R. Kolber
Associate Professor in the Department of Family Medicine, at the University of Alberta in Edmonton.
MD CCFP MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • eLetters
  • Info & Metrics
  • PDF
Loading

Clinical question

Do nicotine electronic cigarettes (NECs) help smokers decrease or quit smoking?

Bottom line

Smokers motivated to quit who used NECs had similar quit rates compared with those using nicotine patches (NPs), but 1 in 7 reduced daily cigarette consumption by 50% or more. The long-term adverse effects are unknown.

Evidence

Evidence includes 2 high-quality industry-supported RCTs in which the mean age was in the early 40s and participants were each smoking about 1 pack per day.1,2

  • In 657 smokers in New Zealand motivated to quit who were randomized to NECs, NPs, or placebo electronic cigarettes (PECs) for 12 weeks,1 at 6 months

    • -there was no statistical difference in proportion of quitters (NECs 7.3%, NPs 5.8%, PECs 4.1%); and

    • -statistically significantly more people had a 50% or greater reduction in daily cigarette use with NECs (57%) versus NPs (41%) (NNT = 7), but not PECs (45%).

  • In 300 smokers in Italy (not contemplating quitting or interested in a cessation program) randomized to NECs, tapered-dose NECs, or PECs for 12 weeks,2 at 12 months

    • -similar outcomes were achieved with NECs and tapered-dose NECs (so results were combined); and

    • -significantly more people quit while using NECs (11.0%) than PECs (4.0%); NNT = 15, P = .04.

    • -No difference in 50% or more reduction of daily cigarette use with NECs (14.5%) versus PECs (12.0%).

  • Overall adverse events:

    • -Adverse events were similar between groups in RCTs.1,2

    • -Cohort studies were limited by small sample sizes and short duration.3

    • -Mouth and throat irritation were most often reported.3

Context

  • Electronic cigarettes (e-cigarettes) are battery operated and vaporize liquids and flavours into an aerosol.2–4 Many are manufactured by makers of traditional cigarettes.5

  • Toxins in NECs are usually present at lower levels than in traditional cigarettes,6,7 but occasionally there are higher levels (eg, formaldehyde level might be higher in variable-power systems set at high voltage).8

  • Most NEC users are former or current smokers.9,10

  • Between 2011 and 2014, US high school students’ use of NECs increased (1.5% to 13.4%), while their use of traditional cigarettes decreased (15.8% to 9.2%).11

  • Currently NECs are banned in Canada.12

    • -Health Canada and the FDA are deciding how to regulate e-cigarettes, including addressing health warnings and marketing toward minors.10,12,13

    • -The WHO advises caution (especially for adolescents and pregnant women),4 while Public Health England supports e-cigarettes for smoking cessation and reduction.9

Implementation

Clinicians should ask all adults about tobacco use and their readiness to quit,14 as current smokers live 10 years fewer than those who have never smoked.15 Patients seeking to use e-cigarettes to help them quit should not be dissuaded, but might consider other cessation aids (eg, nortriptyline, varenicline, bupropion, NPs), given the greater evidence of their efficacy and safety.16 Licensing NECs as a cessation aid would help ensure products meet a quality standard17 and aid in tracking harms.

Notes

Tools for Practice articles in Canadian Family Physician (CFP) are adapted from articles published on the Alberta College of Family Physicians (ACFP) website, summarizing medical evidence with a focus on topical issues and practice-modifying information. The ACFP summaries and the series in CFP are coordinated by Dr G. Michael Allan, and the summaries are co-authored by at least 1 practising family physician and are peer reviewed. Feedback is welcome and can be sent to toolsforpractice{at}cfpc.ca. Archived articles are available on the ACFP website: www.acfp.ca.

Footnotes

  • The opinions expressed in Tools for Practice articles are those of the authors and do not necessarily mirror the perspective and policy of the Alberta College of Family Physicians.

  • Copyright© the College of Family Physicians of Canada

References

  1. 1.↵
    1. Bullen C,
    2. Howe C,
    3. Laugesen M,
    4. McRobbie H,
    5. Parag V,
    6. Williman J,
    7. et al
    . Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet 2014;382(9905):1629-37.
    OpenUrl
  2. 2.↵
    1. Caponnetto P,
    2. Campagna D,
    3. Cibella F,
    4. Morjaria JB,
    5. Caruso M,
    6. Russo C,
    7. et al
    . Efficiency and Safety of an Electronic Cigarette (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One 2013;8(6):e66317. Erratum in: PLoS One 2014;9(1).
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. McRobbie H,
    2. Bullen C,
    3. Hartmann-Boyce J,
    4. Hajek P
    . Electronic cigarettes for smoking cessation and reduction. Cochrane Database Syst Rev 2014;(12):CD010216.
  4. 4.↵
    1. World Health Organization
    . Conference of the parties to the WHO Framework Convention on Tobacco Control. Geneva, Switz: World Health Organization; 2014.
  5. 5.↵
    1. Kamerow D
    . Big tobacco lights up e-cigarettes. Good news or bad? BMJ 2013;346:f3418.
    OpenUrlFREE Full Text
  6. 6.↵
    1. Goniewicz ML,
    2. Knysak J,
    3. Gawron M,
    4. Kosmider L,
    5. Sobczak A,
    6. Kurek J,
    7. et al
    . Levels of selected carcinogens and toxicants in vapor from electronic cigarettes. Tob Control 2014;23(2):133-9.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Hahn J,
    2. Monakhova YB,
    3. Hengen J,
    4. Kohl-Himmelseher M,
    5. Schüssler J,
    6. Hahn H,
    7. et al
    . Electronic cigarettes: overview of chemical composition and exposure estimation. Tob Induc Dis 2014;12(1):23.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Jensen RP,
    2. Luo W,
    3. Pankow JF,
    4. Strongin RM,
    5. Peyton DH
    . Hidden formaldehyde in e-cigarette aerosols. N Engl J Med 2015;372(4):392-4.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. McNeill A,
    2. Brose LS,
    3. Calder R,
    4. Hitchman SC
    . E-cigarettes: an evidence update. London, Engl: Public Health England; 2015.
  10. 10.↵
    1. McMillen RC,
    2. Gottlieb MA,
    3. Winickoff JP
    . E-cigarettes—the roles of regulation and clinicians. JAMA Intern Med 2015;175(10):1603-4.
    OpenUrlPubMed
  11. 11.↵
    1. Arrazola RA,
    2. Singh T,
    3. Corey CG,
    4. Husten CG,
    5. Neff LJ,
    6. Apelberg BJ,
    7. et al
    . Tobacco use among middle and high school students—United States, 2011–2014. MMWR Morb Mortal Wkly Rep 2015;64(14):381-5.
    OpenUrlPubMed
  12. 12.↵
    1. Labonté R,
    2. Lencucha R
    . Regulating electronic cigarettes: finding the balance between precaution and harm reduction. CMAJ 2015;187(12):862-3.
    OpenUrlFREE Full Text
  13. 13.↵
    1. Morin V
    . Federal report calls for regulation of e-cigarettes. CMAJ 2015;187(7):487.
    OpenUrlFREE Full Text
  14. 14.↵
    1. Siu AL,
    2. U.S. Preventive Services Task Force
    . Behavioral and pharmacotherapy interventions for tobacco smoking cessation in adults, including pregnant women: USPSTF recommendation statement. Ann Intern Med 2015;163(8):622-34.
    OpenUrlPubMed
  15. 15.↵
    1. Jha P,
    2. Ramasundarahettige C,
    3. Landsman V,
    4. Rostron B,
    5. Thun M,
    6. Anderson RN,
    7. et al
    . 21st-Century hazards of smoking and benefits of cessation in the United States. N Engl J Med 2013;368(4):341-50.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Cahill K,
    2. Stevens S,
    3. Perera R,
    4. Lancaster T
    . Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev 2013;(5):CD009329.
  17. 17.↵
    1. McKee M,
    2. Capewell S
    . Evidence about electronic cigarettes: a foundation built on rock or sand? BMJ 2015;351:h4863.
    OpenUrlFREE Full Text
PreviousNext
Back to top

In this issue

Canadian Family Physician: 62 (1)
Canadian Family Physician
Vol. 62, Issue 1
1 Jan 2016
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on The College of Family Physicians of Canada.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Electronic cigarettes: help, hurt, or hype?
(Your Name) has sent you a message from The College of Family Physicians of Canada
(Your Name) thought you would like to see the The College of Family Physicians of Canada web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Electronic cigarettes: help, hurt, or hype?
Elfriede Cross, Scott Garrison, Michael R. Kolber
Canadian Family Physician Jan 2016, 62 (1) 51;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Electronic cigarettes: help, hurt, or hype?
Elfriede Cross, Scott Garrison, Michael R. Kolber
Canadian Family Physician Jan 2016, 62 (1) 51;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Clinical question
    • Bottom line
    • Evidence
    • Context
    • Implementation
    • Notes
    • Footnotes
    • References
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Practice

  • Approach to diagnosis and management of childhood attention deficit hyperactivity disorder
  • Determining if and how older patients can safely stay at home with additional services
  • Managing type 2 diabetes in primary care during COVID-19
Show more Practice

Tools for Practice

  • Treating dementia with brain amyloid medications
  • Exercise and pharmacologic management of fibromyalgia
  • Mirabegron for overactive bladder
Show more Tools for Practice

Similar Articles

Navigate

  • Home
  • Current Issue
  • Archive
  • Collections - English
  • Collections - Française

For Authors

  • Authors and Reviewers
  • Submit a Manuscript
  • Permissions
  • Terms of Use

General Information

  • About CFP
  • About the CFPC
  • Advertisers
  • Careers & Locums
  • Editorial Advisory Board
  • Subscribers

Journal Services

  • Email Alerts
  • Twitter
  • LinkedIn
  • Instagram
  • RSS Feeds

Copyright © 2026 by The College of Family Physicians of Canada

Powered by HighWire